Kyoko Kameyama
No ORCID on file
· 2 papers in corpus
· active 2016-2018
PURPOSE: Seromucinous borderline tumor (SMBT) is a newly categorized ovarian tumor in the 2014 revised World Health Organization (WHO) classification. SMBT is similar to serous borderline tumor (SBT) on MRI reflecting their pathological fin…